vivoPharm
Toggle navigation

Contact vivoPharm:Contact Us | Email

Investors My CGI Reports RDX Portal Order a Test
FacebookTwitterLinkedIn YouTube
  • Home
  • Discovery
    • Tumor Models
      • Xenograft
      • Syngeneic
    • Cell-based Assays
  • Development
    • Mammalian Toxicology
    • Safety Pharmacology
    • Genetic Toxicology
    • In vitro Toxicology
    • Analytical Services
    • Pathology Services
  • About Us
    • Company
    • Global Management
  • Visit CGI

Navigation

Home Discovery
    Tumor Models
      Xenograft Syngeneic
    Cell-based Assays
Development
    Mammalian Toxicology Safety Pharmacology Genetic Toxicology In vitro Toxicology Analytical Services Pathology Services
About Us
    Company Global Management
Visit CGI

vivoPharm Accesses New Cancer Models for US Market

January 18, 2012 10:19 pmAugust 8, 2017

vivoPharm Pty Ltd has entered into a partnership with Experimental Pharmacology & Oncology Berlin-Buch GmbH (EPO), one of Germany’s leading preclinical oncology testing company.

Read More

Previous ArticlevivoPharm announces new Chairman of the BoardNext ArticlevivoPharm acquires RDDT
Vivopharm Logo white

vivoPharm

  • vivoPharm HQ Level 3 Office 29, 240 Plenty Road Bundoora VIC 3083 Australia
White Facebook Icon
White Twitter Icon
White Linkedin Icon
YouTube Icon

About Us

  • Company
  • Global Management
  • Contact Us

Discovery

  • Model Portofolio

Search VivoPharm.com

Copyright © 2017 vivoPharm Pty. Ltd.
Menu
  • Discovery
    • Tumor Models
      • Xenograft
      • Syngeneic
    • Cell-based Assays
  • Development
    • Mammalian Toxicology
    • Safety Pharmacology
    • Genetic Toxicology
    • In vitro Toxicology
    • Analytical Services
    • Pathology Services
  • About Us
    • Company
    • Global Management
  • Visit CGI
Contact Us
FacebookTwitterLinkedIn YouTube